Morris Financial Concepts’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Sell
1,635
-506
-24% -$513K 0.51% 35
2025
Q4
$2.3M Sell
2,141
-13
-0.6% -$12.4K 0.81% 23
2025
Q3
$1.64M Sell
2,154
-84
-4% -$62.5K 0.59% 29
2025
Q2
$1.74M Buy
2,238
+43
+2% +$33.4K 0.69% 24
2025
Q1
$1.81M Buy
2,195
+557
+34% +$463K 0.76% 23
2024
Q4
$1.26M Sell
1,638
-26
-2% -$21.5K 0.54% 31
2024
Q3
$1.47M Sell
1,664
-513
-24% -$461K 0.63% 29
2024
Q2
$1.97M Sell
2,177
-73
-3% -$58.4K 0.94% 17
2024
Q1
$1.75M Buy
2,250
+3
+0.1% +$2.13K 0.9% 19
2023
Q4
$1.31M Sell
2,247
-13
-0.6% -$7.59K 0.75% 27
2023
Q3
$1.21M Sell
2,260
-50
-2% -$25.8K 0.81% 27
2023
Q2
$1.08M Hold
2,310
0.7% 27
2023
Q1
$793K Hold
2,310
0.56% 34
2022
Q4
$845K Buy
2,310
+111
+5% +$39.4K 0.68% 31
2022
Q3
$711K Sell
2,199
-138
-6% -$43.7K 0.74% 26
2022
Q2
$758K Buy
2,337
+95
+4% +$28.5K 0.72% 27
2022
Q1
$642K Buy
2,242
+223
+11% +$57.4K 0.54% 29
2021
Q4
$558K Buy
+2,019
New +$512K 0.47% 33

Other funds holding LLY

Morris Financial Concepts's LLY Position: Q1 2026 in Review

Morris Financial Concepts reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $513K and leaving 1,635 shares worth $1.5M. The position accounts for 0.51% of the portfolio, ranked #35.

Morris Financial Concepts first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.3M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Morris Financial Concepts held 1,635 shares of Eli Lilly worth $1.5M as of Q1 2026.
  • Morris Financial Concepts sold 506 Eli Lilly shares in Q1 2026, an estimated $513K.
  • Eli Lilly made up 0.51% of Morris Financial Concepts's portfolio in Q1 2026, its #35 holding.
  • Morris Financial Concepts first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Morris Financial Concepts's Eli Lilly position peaked at $2.3M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Morris Financial Concepts's 13F filing for Q1 2026, filed 17 Apr 2026.